目的探讨激素治疗溃疡性结肠炎(UC)的黏膜愈合程度与其预后的相关性。方法对接受激素治疗(n=86)的UC患者随访2年。首先在治疗6个月后对其进行早期临床疗效评价(Powel—Tuck,PW)和组织病理学分级,并将患者分为完全应答(A组:PT,0~1分;病理分级,0级)、部分应答(B组:PT,0~1分;病理分级,I~Ⅱ级)和无应答(c组:PT≥2分;病理分级≥Ⅲ级)。随后对其疾病复发、再入院、结肠手术、免疫抑制剂使用等预后情况进行追踪,评估早期治疗UC的黏膜愈合程度和其后期预后的相关性。结果2年后,完全(A组)和部分应答(13组)患者预后情况在以下方面出现差异:再人院率[A组27.5% vs 13组44.1%;P=0.018;OR=2.24;95%CI(1.11~3.98)]、免疫抑制治疗[A组7.5%VSB组26.5%;P=0.008;OR=5.67;95%CI(3.24~8.93)]、结肠切除术[A组0.00%vs B组17.6%;P=0.035;OR=5.43;95%CI(2.14—7.64)]。结论激素治疗UC早期达到黏膜愈合与其后期良好的预后存在明显的正相关。
Objective To evaluate the relationship between mucosal healing and outcomes in ulcerative colitis (UC) after treatment with corticosteroids. Methods Patients with UC who were prescribed corticosteroid therapy (n = 86) were followed up for 2 years. They were evaluated by clinical (Powel-Tuck, PT) and histopathology grading after 6 months, outcomes at 6 months ( early response) were used to identify patients with complete ( group A : PT, 0 - 1 ; his- topathology grading, 0) , partial ( group B : PT, 0 - 1 ; histopathology grading, Ⅰ-Ⅱ) , or no response (group C : PT 2 ; histopathology grading≥Ⅲ ). The association between mucosal healing and late outcomes was assessed. Results After 2 years, there were significant differences between complete and partial responders in the rates of hospitalization [ 27.5 % in group A vs 44.1% in group B ; P = 0.018 ; OR = 2.24 ;95 % CI ( 1.11 - 3.98 ) ], immunosuppression therapy [(7.5% in group A vs26.5% in group B; P=0.008; OR=5.67;95%CI(3.24-8.93)] , coleetomy [0.00% in group A vs 17.6% in group B ; P = 0. 035 ; OR = 5.43 ;95% CI(2.14 - 7.64) ]. Conclusion Mucosal healing after corticosteroid therapy is associated with late outcomes in UC.